Araxes Pharma LLC
Records under this name other than the patents Araxes Pharma LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 36 patents it holds.
Showing 1 to 10 of 10 · Back to Araxes Pharma LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,377,441 | Covalent Inhibitors of Kras Lapsed on the fee record Ended Jul 5, 2026 · High confidence | Lapsed on the fee record | Ended Jul 5, 2026 | High confidence |
| US 10,011,600 | Methods and Compositions for Inhibition of Ras Lapsed on the fee record Ended Jul 3, 2026 · High confidence | Lapsed on the fee record | Ended Jul 3, 2026 | High confidence |
| US 11,358,959 | Benzothiophene and benzothiazole compounds and methods of use thereof Lapsed on the fee record Ended Jun 14, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 14, 2026 | From the USPTO record |
| US 9,862,701 | Inhibitors of Kras G12C Mutant Proteins Lapsed on the fee record Ended Jan 9, 2026 · High confidence | Lapsed on the fee record | Ended Jan 9, 2026 | High confidence |
| US 9,810,690 | Method for screening inhibitors of Ras Lapsed on the fee record Ended Nov 7, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 7, 2025 | From the USPTO record |
| US 11,136,308 | Substituted quinazoline and quinazolinone compounds and methods of use thereof Lapsed on the fee record Ended Oct 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 5, 2025 | From the USPTO record |
| US 9,745,319 | Irreversible covalent inhibitors of the GTPase K-Ras G12C Lapsed on the fee record Ended Aug 29, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 29, 2025 | From the USPTO record |
| US 10,919,850 | Covalent Inhibitors of Kras G12C Surrendered on reissue Surrendered on reissue Aug 12, 2025 · High confidence | Surrendered on reissue | Surrendered on reissue Aug 12, 2025 | High confidence |
| US 10,829,458 | Substituted Quinazoline Compounds and Methods of Use Thereof Surrendered on reissue Surrendered on reissue Jul 15, 2025 · High confidence | Surrendered on reissue | Surrendered on reissue Jul 15, 2025 | High confidence |
| US 11,059,819 | Fused hetero-hetero bicyclic compounds and methods of use thereof Lapsed on the fee record Ended Jul 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 13, 2025 | From the USPTO record |